Sotatercept Pulmonary Hypertension Observational Registry

Mayo Clinic

Summary

The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic. Exclusion Criteria: * Adults lacking capacity to consent

Location

Mayo Clinic
Rochester, Minnesota

Summary

Eligibility

Location

Conditions